Status:
UNKNOWN
Treatment of Supraventricular Tachycardia in Patients With Non-cardiac Surgery by Dexmedetomidine
Lead Sponsor:
Lianyungang Hospital Affiliated Bengbu Medical College
Conditions:
Perioperative Period
Eligibility:
All Genders
35-61 years
Phase:
NA
Brief Summary
Supraventricular tachycardia (SVT) is a common arrhythmia in the perioperative period, which is associated with adverse stimulus such as cardiovascular risk factors, emotional tension, hypoxia, CO2 ac...
Detailed Description
Forty patients with SVT of both sexes, aged 35-61 yr, of American Society of Anesthesiologists physical status Ⅰ-Ⅱ, who undergo elective surgery, were randomly divided into two groups (n=30) including...
Eligibility Criteria
Inclusion
- Patients with supraventricular tachycardia
Exclusion
- Patients who suffered from significant hemodynamic instability, and can not receive dexmedetomidine and midazolam, were thus excluded from the study.
- Patients with other types of arrhythmia, not SVT, abnormal liver and kidney function and anaesthesia-related drug allergy, were excluded from the study.
Key Trial Info
Start Date :
February 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04284150
Start Date
February 26 2020
End Date
August 30 2020
Last Update
February 25 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.